Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

boehringer ingelheim pharmaceuticals, inc. - olodaterol hydrochloride (unii: 65r445w3v9) (olodaterol - unii:vd2ysn1afd) - olodaterol 2.5 ug - striverdi respimat is a long-acting beta2 -agonist indicated for long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and/or emphysema. striverdi respimat is not indicated to treat acute deteriorations of copd [see warnings and precautions (5.2) ]. striverdi respimat is not indicated to treat asthma. the safety and effectiveness of striverdi respimat in asthma have not been established. use of a laba, including striverdi respimat, without an inhaled corticosteroid is contraindicated in patients with asthma [see warnings and precautions (5.1) ]. striverdi respimat is not indicated for the treatment of asthma. risk summary there are no adequate and well-controlled clinical studies with striverdi respimat in pregnant women to inform of drug-associated risk of adverse pregnancy-related outcomes. there are clinical considerations with the use of striverdi respimat in pregnant women [see clinica

Kanada - Englisch - Health Canada

strivectin operating company inc - avobenzone; octinoxate; octisalate; octocrylene; oxybenzone - lotion - 3.0%; 7.5%; 5.0%; 2.7%; 4.0% - avobenzone 3.0%; octinoxate 7.5%; octisalate 5.0%; octocrylene 2.7%; oxybenzone 4.0% - sunscreen agents

Kanada - Englisch - Health Canada

strivectin operating company inc - avobenzone; octinoxate; octocrylene - stick - 2.7%; 3.0%; 3.0% - avobenzone 2.7%; octinoxate 3.0%; octocrylene 3.0% - sunscreen agents

Kanada - Englisch - Health Canada

strivectin operating company inc - titanium dioxide; octinoxate; octisalate - lotion - 8.0%; 7.5%; 3.0% - titanium dioxide 8.0%; octinoxate 7.5%; octisalate 3.0% - sunscreen agents

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

strivectin operating company inc. - homosalate (unii: v06sv4m95s) (homosalate - unii:v06sv4m95s), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y) - homosalate 75 mg in 1 ml - purpose sunscreen uses: - for prevention of sunburn

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

strivectin operating company, inc. - avobenzone 2.7% octinoxate 3.0% octocrylene 3.0%, sunscreen - helps prevent sunburn

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

strivectin operating company, inc. - avobenzone 2.7% octinoxate 3.0% octocrylene 3.0%, sunscreen - helps prevent sunburn

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

strivectin operating company, inc. - avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y) - sunscreen helps prevent sunburn - if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

strivectin operating company, inc. - octinoxate 7.50% octisalate 3.00% titanium dioxide 8.00%, sunscreen - helps prevent sunburn

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

strivectin operating company, inc. - octinoxate 7.50% octisalate 3.00% titanium dioxide 8.00%, sunscreen - helps prevent sunburn